How is Simponi (golimumab) administered, and under what conditions may patients self-inject?

Simponi (golimumab) is administered by subcutaneous injection, and patients may self-inject after proper training in subcutaneous injection technique if their physician considers it appropriate, with medical follow-up as necessary.